The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 Pandemic.

MLA

Diak, Ida-Lina, et al. “The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic.” Drug Safety, vol. 46, no. 2, Feb. 2023, pp. 145–55. EBSCOhost, https://doi.org/10.1007/s40264-022-01256-2.

APA

Diak, I.-L., Swank, K., McCartan, K., Beganovic, M., Kidd, J., Gada, N., Kapoor, R., Wolf, L., Kangas, L., Wyeth, J., Salvatore, T., Fanari, M., LeBoeuf, A. A., Mishra, P., Blum, M. D., & Dal Pan, G. (2023). The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic. Drug Safety, 46(2), 145–155. https://doi.org/10.1007/s40264-022-01256-2

Chicago

Diak, Ida-Lina, Kimberley Swank, Kate McCartan, Maya Beganovic, James Kidd, Neha Gada, Rachna Kapoor, et al. 2023. “The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic.” Drug Safety 46 (2): 145–55. doi:10.1007/s40264-022-01256-2.